Friday, September 30, 2022

561.316.3330

Biotechnology News Magazine

Scipio bioscience Announces Its Revolutionary Asteria Single-cell RNA-seq Kit & Companion Cytonaut© Analysis Software Are Now Commercially Available

Latest Posts

City of Hope to Accelerate Immunotherapy Research & Treatment Innovation with $15 Mil Gift from Ted Schwartz Family

Ted Schwartz, who is now cancer free, achieved complete remission at City of Hope in 2020 with the center's leading CAR T cell therapy after a 16-year battle with lymphoma, provided the gift to City of Hope to advance treatment options that offer better outcomes and quality of life for people living with cancer.

Neurocrine Biosciences Appoints Dr Ingrid Delaet as Chief Regulatory Officer

Prior to joining Neurocrine Biosciences, Dr Ingrid Delaet served as Senior Vice President, Regulatory Affairs at Intercept Pharmaceuticals, which she joined in 2016.

Astrea Bioseparations Introduces Nereus LentiHERO, a Fit-for-purpose Solution for Lentiviral Vector Purification

“We believe that AstreAdept will be a game-changer,” explained Astrea Bioseparations’ CEO Terry Pizzie. “Our approach was to rapidly develop and incorporate this material into the Nereus LentiHERO, a simple, fit-for-purpose device that radically transforms how lentivirus can be purified [in terms of speed, recovery, and efficiency].

At Pack Expo, Schreiner MediPharm to Debut Functional Labels Designed from More Sustainable Materials

Schreiner MediPharm advises he new label concepts are based on existing items in Schreiner MediPharm’s roster of functional labeling solutions.

Asteria©, the latest breakthrough single-cell RNA-sequencing kit developed by Scipio bioscience, is now commercially available for any researcher worldwide. This innovative hydrogel-based benchtop kit enables the transcriptomic profiling of 10,000 individual cells per sample, instrument-free.

By purchasing the kit, researchers also gain access to its intuitive and entirely cloud-based analysis software, Cytonaut©. The combination of the kit and software is a comprehensive end-to-end single-cell solution – sequencing excepted – accessible to any scientist with or without prior knowledge of single-cell technology and bioinformatics.

The new kit offers an opportunity for both single-cell researchers looking for an inventive alternative to the solutions offered by the current market and for scientists new to the field wanting to generate their first single-cell datasets without a heavy initial investment. At an affordable price, a researcher can process fresh samples of 10,000 cells immediately with a stable stopping point within two hours, simplifying sample management at the laboratory and limiting transcriptional changes. The straightforward hydrogel technology bypasses the use of microfluidics and nano-wells, allowing the generation of barcoded cDNA entirely on the workbench and independently from the studied cell types.

For use with Asteria, Scipio bioscience developed Cytonaut, an end-to-end software solution covering pre- and post-processing analysis as well as interactive data visualization and generation of publication-ready results and figures. Hosted in a secure cloud infrastructure, it guides the user through the analysis step by step, enables researchers to free themselves from heavy computing resources and let them exploit their data without prerequired knowledge in bioinformatics.

“We are achieving our goal of bringing a single-cell solution to every lab”, says Pierre Walrafen, CEO at Scipio bioscience, “empowering researchers to use single-cell sequencing unhindered by the technical, logistical and cost limitations of current solutions. With the Asteria kit ready in the freezer for on-the-spot profiling and cloud-based Cytonaut accessible from any computer for immediate bioinformatic analysis, anyone can start generating high-quality single-cell data on their own terms.”

“When investigating the impact of radiotherapy on lung tissue, it is essential that we analyse our samples immediately to measure a transcriptomic profile as close to physiological conditions as possible”, comments Dr. Charles Fouillade from the Repair, Radiation and Innovative Anticancer Therapies team led by Prof. Arturo Londoño at Curie Institute, Paris, France. “And thanks to the Asteria kit protocol, we can quickly capture the mRNAs and resume the experiment the next day without loss of gene expression. The Asteria kit and Cytonaut software are extremely easy to use and will undoubtedly facilitate access to single-cell data for research teams throughout the world.”

To distribute the Asteria single-cell RNA-seq kit, Scipio bioscience has partnered with Witec AG in Switzerland, BioCat in Austria and Germany, Ozyme in France, and Thistle Scientific in the UK and Ireland. For any other countries, orders can be made directly at Scipio bioscience. Early purchases will benefit from a substantially lower innovator’s price.

 

Latest Posts

Learn More

spot_img

Subscribe

spot_img

Our Sister Publication

Medical Device News Magazine